Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Fingolimod in Schizophrenia Patients Who Have Suboptimal Responses to Antipsychotic Drug Treatment

NCT01779700 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT01779700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01779700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Fingolimod in Schizophrenia Patients Who Have Suboptimal Responses to Antipsychotic Drug Treatment
Lead sponsor
Indiana University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2016
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia